Anika Therapeutics Stock
Anika Therapeutics Stock
A very strong showing by Anika Therapeutics today, with an increase of €0.90 (12.770%) compared to yesterday's price.
Anika Therapeutics is currently one of the favorites of our community with 9 Buy predictions and no Sell predictions.
With a target price of 15 € there is a hugely positive potential of 88.68% for Anika Therapeutics compared to the current price of 7.95 €.
Our community identified positive and negative aspects for Anika Therapeutics stock for the coming years. 1 users see the criterium "Brand" as a plus for the Anika Therapeutics stock. On the other hand our users think that "EBIT growth" could be a problem in the future.
Pros and Cons of Anika Therapeutics in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Anika Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Anika Therapeutics | 12.770% | -4.082% | -10.759% | -57.784% | -11.875% | -75.176% | -76.809% |
| Evolus Inc | -1.940% | -4.478% | -32.632% | -71.343% | -29.541% | -56.364% | -29.308% |
| Madrigal Pharmaceuticals inc. | -0.100% | -1.024% | -17.995% | 28.868% | -16.630% | 57.424% | 333.007% |
| Heron Therapeutics Inc. | -1.610% | -2.732% | 8.796% | -28.528% | 5.476% | -55.860% | -92.260% |
Comments
Anika Therapeutics (NASDAQ:ANIK) had its price target raised by analysts at Barrington Research from $15.00 to $16.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics (NASDAQ:ANIK) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $15.00 price target on the stock.
Show more
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics Inc. (NASDAQ: ANIK) had its price target lowered by analysts at Barrington Research from $19.00 to $15.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ANIK provided by MarketBeat